Century Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Century Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Century Therapeutics Inc
Rating: 1.67783325
Author: Trendlyne DVM scores

about

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its b...

2.19 -0.06 (-2.67%)

27.96% Fall from 52W High

1.5M

XNAS Volume

XNAS 13 Jul, 2026 3:48 PM (EDT)

Not Eligible

Expensive Valuation

11.8 / 100

Technically Neutral

55.3 / 100

1Yr Price target upside is 117%

4 analysts

Century Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Century Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its b...

27.96% Fall from 52W High

SWOT Analysis

Century Therapeutics Inc Live Price Chart

Century Therapeutics Inc Live Price Chart